[1]
S. Weissman, S. Saleem, and D. Al-Dulaimi, “Gastrointestinal and liver adverse effects of anti-tumoral immune therapy: from recognition to treatment ”, Gastroenterol Hepatol Bed Bench, vol. 14, no. 3, pp. 195–199, Jun. 2021.